The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL909     8-chloro-10-(3- dimethylaminopropyl)phenoth...

Synonyms: SureCN2389266, CCG-37119, NSC-131053, NCI131053, NSC131053, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Psychiatry related information on 7-Hydroxy-2-chloro-10-[3'-(dimethylamino)-N-propyl]phenothiazine

  • These showed that the most significant correlations occurred when symptoms with high diagnostic significance for schizophrenia (Group 1) and symptoms rating perceptual disorders (P) were correlated with plasma 7OHCPZ levels in plasma samples taken before the first morning dose of CPZ [1].

High impact information on 7-Hydroxy-2-chloro-10-[3'-(dimethylamino)-N-propyl]phenothiazine


Analytical, diagnostic and therapeutic context of 7-Hydroxy-2-chloro-10-[3'-(dimethylamino)-N-propyl]phenothiazine


  1. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis. Phillipson, O.T., McKeown, J.M., Baker, J., Healey, A.F. The British journal of psychiatry : the journal of mental science. (1977) [Pubmed]
  2. Chemical and electrochemical oxidation of 7-hydroxychlorpromazine. Neptune, M., McCreery, R.L. J. Med. Chem. (1978) [Pubmed]
  3. The presence of 7-hydroxychlorpromazine in CSF of chloropromazine-treated patients. Alfredsson, G., Lindberg, M., Sedvall, G. Psychopharmacology (Berl.) (1982) [Pubmed]
  4. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels. Chetty, M., Gouws, E., Miller, R., Moodley, S.V. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. (1999) [Pubmed]
  5. Radioimmunoassay for the N-oxide metabolite of chlorpromazine in human plasma and its application to a pharmacokinetic study in healthy humans. Yeung, P.K., Hubbard, J.W., Korchinski, E.D., Midha, K.K. Journal of pharmaceutical sciences. (1987) [Pubmed]
  6. The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity. Bronaugh, R.L., Goldstein, M. Psychopharmacology communications. (1975) [Pubmed]
  7. A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies. Yeung, P.K., McKay, G., Ramshaw, I.A., Hubbard, J.W., Midha, K.K. J. Pharmacol. Exp. Ther. (1985) [Pubmed]
WikiGenes - Universities